CN Patent

CN1250292C — 泮托拉唑冻干制剂和泮托拉唑注射剂

Assigned to Takeda GmbH · Expires 2006-04-12 · 20y expired

What this patent protects

泮托拉唑冻干制剂，通过将泮托拉唑、乙二胺四乙酸和/或其适当的盐，及氢氧化钠和/或碳酸钠的水溶液冷冻干燥而得。当重新溶解成注射剂时该制剂具有优良的特性。

USPTO Abstract

泮托拉唑冻干制剂，通过将泮托拉唑、乙二胺四乙酸和/或其适当的盐，及氢氧化钠和/或碳酸钠的水溶液冷冻干燥而得。当重新溶解成注射剂时该制剂具有优良的特性。

Drugs covered by this patent

ibuprofen-lysine (IBUPROFEN LYSINE)

Patent Metadata

Patent number: CN1250292C
Jurisdiction: CN
Classification: —
Expires: 2006-04-12
Drug substance claim: No
Drug product claim: No
Assignee: Takeda GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.